Evidence map›Paper›PMID 36648628›Full record

ArticleThe protein journal2023

Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.

Melvin Selim Atay, Suat Sari, Ebru Bodur

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Melvin Selim AtayDepartment of Medical Biochemistry, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey.ORCID 0000-0003-4985-2362
Suat SariDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100, Ankara, Turkey.ORCID 0000-0002-8248-4218
Ebru BodurDepartment of Medical Biochemistry, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey. bodurebru@yahoo.com.ORCID 0000-0001-5829-5487
Hacettepe University · TRAnkara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholinesterase enzyme family consists of acetylcholinesterase (AChE, 3.1.1.7), the major enzyme responsible for hydrolysis of acetylcholine at cholinergic synapses, and butyrylcholinesterase (BChE, 3.1.1.8) a detoxification enzyme of plasma. Statins are cholesterol-lowering medications utilized as protective medicaments in stroke and Alzheimer's disease, which cholinesterases are associated with. Thus, in this study, we characterized the inhibitory effects and mechanisms of common statins, rosuvastatin, atorvastatin, simvastatin and lovastatin, on human erythrocyte AChE and purified serum BChE using in vitro and in silico methods. Kinetic assays identified statins as selective non-competitive inhibitors of human serum BChE. The IC

Indexed as

ButyrylcholinesteraseHydroxymethylglutaryl-CoA Reductase InhibitorsAcetylcholinesteraseAtorvastatinCholinesterase InhibitorsHumansLovastatinMolecular Docking SimulationRosuvastatin CalciumSimvastatinStructure-Activity RelationshipAcetylcholinesteraseAtorvastatinBCHE protein, humanButyrylcholinesteraseCholinesterase InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsLovastatinRosuvastatin CalciumSimvastatinAcetylcholinesteraseButyrylcholinesteraseLipid MetabolismMolecular DockingStatins

Identifiers

PMID36648628
OpenAlexW4316810835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.